Owner only: item control page
Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: A randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
Lorenzen, Sylvie, Riera Knorrenschild, Jorge, Haag, Georg-Martin, Pohl, Michael, Thuss-Patience, Peter, Bassermann, Florian, Helbig, Ulrike, Weißinger, Florian, Schnoy, Elisabeth, Becker, Klaus, Stocker, Gertraud, Rüschoff, Josef, Eisenmenger, Andreas, Karapanagiotou-Schenkel, Irini and Lordick, Florian (2015) Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: A randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. European Journal of Cancer 51 (5), pp. 569-576.Date of publication of this fulltext: 19 Dec 2024 07:48
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | European Journal of Cancer | ||||
| Publisher: | ELSEVIER SCI LTD | ||||
|---|---|---|---|---|---|
| Place of Publication: | OXFORD | ||||
| Volume: | 51 | ||||
| Number of Issue or Book Chapter: | 5 | ||||
| Page Range: | pp. 569-576 | ||||
| Date | 2015 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin I | ||||
| Identification Number |
| ||||
| Keywords | ADVANCED GASTRIC-CANCER; OPEN-LABEL; KINASE INHIBITOR; SUPPORTIVE CARE; BREAST-CANCER; CHEMOTHERAPY; TRASTUZUMAB; PACLITAXEL; PLACEBO; SURVIVAL; Gastric cancer; HER2; EGFR; Lapatinib | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 60611 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric